Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.
about
Screening for genital chlamydia infectionPopulation-based biomedical sexually transmitted infection control interventions for reducing HIV infectionThe association of sexual behaviors with socioeconomic status, family structure, and race/ethnicity among US adolescentsRandomized controlled trials of interventions to prevent sexually transmitted infections: learning from the past to plan for the future.Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in micePelvic inflammatory disease: improving awareness, prevention, and treatmentPrevalence of Chlamydia trachomatis among Childbearing Age Women in India: A Systematic ReviewPrevalence of genital Chlamydia trachomatis in Iran: a systematic review and meta-analysisDiagnosis and Management of Uncomplicated Chlamydia trachomatis Infections in Adolescents and Adults: Summary of Evidence Reviewed for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment GuidelinesEffectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementationPromoting chlamydia screening with posters and leaflets in general practice--a qualitative study.Chlamydia screening in England: a qualitative study of the narrative behind the policy.The clinical diagnosis of pelvic inflammatory disease--reuse of electronic medical record data from 189 patients visiting a Swedish university hospital emergency department.Gender Differences in Bacterial STIs in CanadaPopulation prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in the Netherlands. Should asymptomatic persons be tested during population-based Chlamydia screening also for gonorrhoea or only if chlamydial infection is found?Interventions for increasing chlamydia screening in primary care: a reviewConversant or clueless? Chlamydia-related knowledge and practice of general practitioners in Western Australia.Monitoring county-level chlamydia incidence in Texas, 2004 - 2005: application of empirical Bayesian smoothing and Exploratory Spatial Data Analysis (ESDA) methods.A pilot qualitative analysis of the psychosocial factors which drive young people to decline chlamydia testing in the UK: implications for health promotion and screening.Evidence based case report: chlamydia infection in general practice.Sexuality and health: the hidden costs of screening for Chlamydia trachomatis.Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: implications of first results for the analysisA national strategic plan for reducing the burden of sexually transmitted infections in Israel by the year 2025.Efficacy of a motivational behavioral intervention to promote chlamydia and gonorrhea screening in young women: a randomized controlled trial.The changing landscape of controlling sexually transmitted infections in the U.S. militaryRationale, design, and results of the first screening round of a comprehensive, register-based, Chlamydia screening implementation programme in the Netherlands.Pathogenesis of Chlamydia induced pelvic inflammatory disease.Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014Decision analysis: point-of-care Chlamydia testing vs. laboratory-based methods.Are adolescents being screened for sexually transmitted diseases?Confirming positive results of nucleic acid amplification tests (NAATs) for Chlamydia trachomatis: all NAATs are not created equal.Chlamydia Trachomatis and Neisseria Gonorrhoeae prevalence among women of reproductive age living in urogenital schistosomiasis endemic area in Ghana.Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trialScreening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysisEvidence based health policy report. Screening for genital chlamydial infection.Efficacy of home sampling for screening of Chlamydia trachomatis: randomised study."Does ligase chain reaction assay of urine in the diagnosis of Chlamydia trachomatis offer significant improvement over existing diagnostic tests?"--a critical appraisal of the evidenceIs Europe ready for STD screening?Chlamydia screening: which sample for which technique?Is screening for Chlamydia trachomatis infection cost effective?
P2860
Q24202065-870C3B53-08FB-464A-95ED-6A52E64AF51DQ24235716-AC495CD5-3811-4B5F-833F-DF5EE2C71CF5Q24544062-764E93A6-B3D7-4E71-BD95-CF56FCA71E0AQ24600011-BD642A07-75EC-43C8-B62F-A28500263271Q24813686-C19D9998-68CB-4AAA-B2A8-9F12480B172DQ26992247-9442A998-52AB-440B-9159-93D62709CAA9Q28066907-577F2C68-8F91-42C1-A8B5-06C3116D52FCQ28081641-998072C7-2A52-42D7-94DF-2688C3552269Q28082170-C65737E2-8A96-479B-A445-5B42E75C0764Q28727534-DAF193EA-A3E5-4E87-9202-0691222C7538Q30491180-5BB9F446-6C9B-46C7-A89C-DFE6441AD525Q30525307-A0850DB0-4CB4-409C-A2A7-4D389C6AA659Q31068513-3D95B4B0-B73C-4BD5-A75B-E016564B3E2AQ33206406-1CB55F47-46D4-4B0B-99A9-4DAAFFE7FA65Q33235710-287894ED-EF06-4ABE-BBF2-76D9C170B96BQ33286652-12510537-FD9F-44C9-B8B3-36800E1BE9F0Q33321718-9C0AB5F7-749A-42EB-840A-D15CEA4E3903Q33412877-2BBE3588-E05D-4CD4-B066-962E741D1F6CQ33538950-6DA281A1-734A-465B-B3AF-4CD58A13730BQ33542653-8C9B4504-CD6E-40AD-9108-DCEE42CBBFB0Q33548198-659BD5C3-9C17-4BBD-A07F-2A5211227711Q33550587-A76C777B-3402-4D56-874F-73EBFB6C29F7Q33576770-E669201B-2E97-4806-82B1-158AF52A81CAQ33636021-BE0B13E1-3868-4CFF-860D-AA38D6CCAD96Q33638658-9F038280-4912-4FCA-9D1A-1EF05C6CFEA0Q33711642-3BAA3EDD-0F35-4374-A817-8296BE44A5D3Q33711646-EFFF1C0B-1892-4DEF-9476-673C25426C4CQ33720510-EC9E6B43-08EF-4D8F-A8F2-BAB3A893830FQ33723477-8E07E562-FBDB-4AE7-8892-F4D949F2C550Q33727982-B80C5C06-C920-4810-AAFB-B163A3F5DDC8Q33752984-7DA7B1EB-F14B-44B2-A79D-54B28F653504Q33767863-81A7B796-658C-43B7-B417-025F072E3E44Q33778605-0BAEAFAE-F98C-4BC0-BE10-25DC5F16BAFEQ33801635-0F2AB413-3533-412D-90F4-7CBB309BA484Q33801861-87F4B4B4-CC05-4E78-A251-7B17A3C71970Q33811003-9362A930-5CAC-4A6A-9CE8-B75B1BE9B743Q33936408-CD3492BB-0179-478E-B6AB-CB5537AFC027Q33936556-0BAAB421-A227-4EB6-B78A-AA361F7B2CFEQ33936561-7CD29431-0AB0-410F-A74A-283EFF473ABEQ33936566-291DB3FF-2C45-4679-A2A5-4C5817F96BB5
P2860
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.
@en
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.
@nl
type
label
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.
@en
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.
@nl
prefLabel
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.
@en
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.
@nl
P2093
P1476
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.
@en
P2093
Andrilla H
Heidrich FE
Stergachis A
P304
P356
10.1056/NEJM199605233342103
P407
P577
1996-05-01T00:00:00Z